Results 151 to 160 of about 7,813 (216)

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Leukemia, 2016
Bleeding because of impaired platelet function is a major side effect of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation (RIPA) in 64 patients with chronic lymphocytic leukemia ...
Alexander Egle
exaly   +2 more sources

Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury

Journal of Trauma and Acute Care Surgery, 2018
BACKGROUND Injury to the blood-brain barrier exposes endothelium rich in von Willebrand factor (vWF), which may play a role in altered platelet aggregation following traumatic brain injury (TBI).
Lucy Z Kornblith, Anamaria J Robles
exaly   +2 more sources

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Blood, 2010
Veronica H Flood, B R Branchford
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo

Thrombosis Research, 2014
Barbara Zieger, Claudia Heilmann
exaly   +2 more sources

Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin

Blood Coagulation and Fibrinolysis, 2014
J. Patzke, U. Budde, A. Huber, Adriana Méndez, H. Muth, T. Obser, E. Peerschke, M. Wilkens, R. Schneppenheim   +8 more
exaly   +2 more sources

Diazo Transfer−Click Reaction Route to New, Lipophilic Teicoplanin and Ristocetin Aglycon Derivatives with High Antibacterial and Anti-influenza Virus Activity: An Aggregation and Receptor Binding Study

Journal of Medicinal Chemistry, 2009
Gyula Batta, Ferenc Sztaricskai, Eszter Ostorházi   +2 more
exaly   +2 more sources

Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function

Journal of Thrombosis and Haemostasis, 2009
V. Flood, Kenneth D. Friedman, J. C. Gill, J. C. Gill, P. A. Morateck, Jeffrey S. Wren, J. P. Scott, J. P. Scott, Robert R Montgomery, Robert R Montgomery   +9 more
exaly   +2 more sources

Ristocetin and Ristocetin-Neomycin for Preoperative Preparation of the Colon

Archives of Surgery, 1958
Interest in antibacterial agents for preoperative preparation of the bowel has stimulated us to evaluate new agents by standardized techniques which permit comparisons of different agents.1,2,7Ristocetin, isolated from the actinomycete Nocardia lurida recovered from a Colorado soil sample, has been reported to be particularly effective against ...
I, COHN, A B, LONGACRE
openaire   +2 more sources

Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions

Blood, 2001
Jing-Fei Dong
exaly   +2 more sources

On the interaction between ristocetin and the ristocetin cofactor (RCOF)

Thrombosis Research, 1977
Abstract The induction of platelet aggregation by the antibiotic ristocet in requires the participation of a plasma factor, Ristocetin CoFactor (RCoF), which is deficient in patients with vonWillebrand's disease. Although it has been shown that ristocetin precipitates fibrinogen, its interaction with RCoF remains obscure.
M, Floyd, W, Burns, D, Green
openaire   +2 more sources